Use of Pharmacy Refill Data As a Measure of Antiretroviral Adherence

Overview

Journal Curr HIV/AIDS Rep

Publisher Current Science

Specialty Infectious Diseases

Date 2008 Mar 28

PMID 18366950

Citations 47

Authors

Robert Grossberg

Robert Gross

Affiliations

Soon will be listed here.

Abstract

Pharmacy refill adherence has become an increasingly important measure of adherence to antiretroviral medications. It offers a simple, inexpensive, and valid method for measuring adherence. Over the past year, there have been several published developments in the use of pharmacy refill data to measure adherence. Given the utility of this adherence measurement, it is likely that pharmacy refill will be the method of choice for measuring antiretroviral adherence in an increasing number of clinical and research settings.

Citing Articles

User-centered adaption of , A novel mhealth application integrating medication reminders with virtual peer support and social/financial incentives to improve medication adherence.

Idigbe I, Were M, Pierce L, Ekelem C, Nmoh A, Gbaja-Biamila T AIDS Care. 2025; 37(2):263-278.

PMID: 39761419 PMC: 11809558. DOI: 10.1080/09540121.2024.2445789.

Antiretroviral therapy adherence among peripartum women with HIV in Kenya: an explanatory mixed methods study using dry blood spot measures and narrative interviews.

Hampanda K, Grubbs H, Castillo-Mancilla J, Anderson P, Thorne J, Helova A AIDS Care. 2024; 36(12):1826-1837.

PMID: 39106970 PMC: 11560731. DOI: 10.1080/09540121.2024.2383885.

Effects of M-DEPTH Model of Depression Care on Maternal Functioning and Infant Developmental Outcomes in the Six Months Post Delivery: Results from a Cluster Randomized Controlled Trial.

Wagner G, Ghosh-Dastidar B, Faherty L, Beyeza-Kashesya J, Nakku J, Nabitaka L Womens Reprod Health (Phila). 2024; 11(2):313-328.

PMID: 39081835 PMC: 11286218. DOI: 10.1080/23293691.2023.2255587.

It's all about connection: Determinants of social support and the influence on HIV treatment interruptions among people living with HIV in British Columbia, Canada.

Tam C, Wesseling T, Wang L, Salters K, Moore D, Dawydiuk N BMC Public Health. 2023; 23(1):2524.

PMID: 38104090 PMC: 10725596. DOI: 10.1186/s12889-023-17416-7.

Antiretroviral treatment interruption and resumption within 16 weeks among HIV-positive adults in Jinan, China: a retrospective cohort study.

Ma J, Jin Y, Jiao K, Wang Y, Gao L, Li X Front Public Health. 2023; 11:1137132.

PMID: 37228714 PMC: 10203161. DOI: 10.3389/fpubh.2023.1137132.

References

Gross R, Yip B, Lo Re 3rd V, Wood E, Alexander C, Harrigan P . A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis. 2006; 194(8):1108-14. DOI: 10.1086/507680. View

Wood E, Montaner J, Yip B, Tyndall M, Schechter M, OShaughnessy M . Adherence and plasma HIV RNA responses to highly active antiretroviral therapy among HIV-1 infected injection drug users. CMAJ. 2003; 169(7):656-61. PMC: 202281. View

Gross R, Zhang Y, Grossberg R . Medication refill logistics and refill adherence in HIV. Pharmacoepidemiol Drug Saf. 2005; 14(11):789-93. DOI: 10.1002/pds.1109. View

Nachega J, Hislop M, Dowdy D, Chaisson R, Regensberg L, Maartens G . Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med. 2007; 146(8):564-73. DOI: 10.7326/0003-4819-146-8-200704170-00007. View

Steiner J, Koepsell T, Fihn S, Inui T . A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care. 1988; 26(8):814-23. DOI: 10.1097/00005650-198808000-00007. View

Yip B, OShaughnessy M, Hogg R, Montaner J . Adherence to triple therapy and viral load response. J Acquir Immune Defic Syndr. 2000; 23(4):360-1. DOI: 10.1097/00126334-200004010-00016. View

Braitstein P, Justice A, Bangsberg D, Yip B, Alfonso V, Schechter M . Hepatitis C coinfection is independently associated with decreased adherence to antiretroviral therapy in a population-based HIV cohort. AIDS. 2006; 20(3):323-31. DOI: 10.1097/01.aids.0000198091.70325.f4. View

Nachega J, Hislop M, Dowdy D, Lo M, Omer S, Regensberg L . Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr. 2006; 43(1):78-84. DOI: 10.1097/01.qai.0000225015.43266.46. View

Wood E, Hogg R, Yip B, Harrigan P, OShaughnessy M, Montaner J . Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4+ cell count is 0.200 to 0.350 x 10(9) cells/L. Ann Intern Med. 2003; 139(10):810-6. DOI: 10.7326/0003-4819-139-10-200311180-00008. View

10.

Laine C, Newschaffer C, Zhang D, Cosler L, Hauck W, Turner B . Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysis. Obstet Gynecol. 2000; 95(2):167-73. DOI: 10.1016/s0029-7844(99)00523-2. View

11.

Turner B, Laine C, Cosler L, Hauck W . Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. J Gen Intern Med. 2003; 18(4):248-57. PMC: 1494846. DOI: 10.1046/j.1525-1497.2003.20122.x. View

12.

Graham J, Bennett I, Holmes W, Gross R . Medication beliefs as mediators of the health literacy-antiretroviral adherence relationship in HIV-infected individuals. AIDS Behav. 2006; 11(3):385-92. DOI: 10.1007/s10461-006-9164-9. View

13.

Harrigan P, Hogg R, Dong W, Yip B, Wynhoven B, Woodward J . Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy. J Infect Dis. 2005; 191(3):339-47. DOI: 10.1086/427192. View

14.

Wood E, Montaner J, Yip B, Tyndall M, Schechter M, OShaughnessy M . Adherence to antiretroviral therapy and CD4 T-cell count responses among HIV-infected injection drug users. Antivir Ther. 2004; 9(2):229-35. View

15.

Palepu A, Tyndall M, Joy R, Kerr T, Wood E, Press N . Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alcohol Depend. 2006; 84(2):188-94. DOI: 10.1016/j.drugalcdep.2006.02.003. View

16.

Turner B, Newschaffer C, Zhang D, Cosler L, Hauck W . Antiretroviral use and pharmacy-based measurement of adherence in postpartum HIV-infected women. Med Care. 2000; 38(9):911-25. DOI: 10.1097/00005650-200009000-00005. View

17.

Wood E, Hogg R, Yip B, Harrigan P, OShaughnessy M, Montaner J . The impact of adherence on CD4 cell count responses among HIV-infected patients. J Acquir Immune Defic Syndr. 2004; 35(3):261-8. DOI: 10.1097/00126334-200403010-00006. View

18.

Steiner J, Prochazka A . The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997; 50(1):105-16. DOI: 10.1016/s0895-4356(96)00268-5. View

19.

Grossberg R, Zhang Y, Gross R . A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol. 2004; 57(10):1107-10. DOI: 10.1016/j.jclinepi.2004.04.002. View

20.

Braithwaite R, Kozal M, Chang C, Roberts M, Fultz S, Goetz M . Adherence, virological and immunological outcomes for HIV-infected veterans starting combination antiretroviral therapies. AIDS. 2007; 21(12):1579-89. PMC: 3460378. DOI: 10.1097/QAD.0b013e3281532b31. View